Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Canopy Growth Corporation (CGC)

1.9   -0.01 (-0.52%) 03-24 16:00
Open: 1.91 Pre. Close: 1.91
High: 1.93 Low: 1.8792
Volume: 4,005,382 Market Cap: 940(M)

Technical analysis

as of: 2023-03-24 4:24:48 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.63     One year: 2.93
Support: Support1: 1.85    Support2: 1.53
Resistance: Resistance1: 2.25    Resistance2: 2.5
Pivot: 2.03
Moving Average: MA(5): 1.9     MA(20): 2.09
MA(100): 2.77     MA(250): 3.48
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 10.1     %D(3): 12
RSI: RSI(14): 33.1
52-week: High: 8.06  Low: 1.85
Average Vol(K): 3-Month: 7,547 (K)  10-Days: 5,953 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CGC ] has closed above bottom band by 21.3%. Bollinger Bands are 56.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.93 - 1.94 1.94 - 1.95
Low: 1.85 - 1.87 1.87 - 1.88
Close: 1.88 - 1.9 1.9 - 1.92

Company Description

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Headline News

Fri, 24 Mar 2023
Wana CEO Whiteman challenges entrepreneurs to 'grow the pie' for cannabis - MarketWatch

Thu, 23 Mar 2023
Where Does Wall Street Think Canopy Growth Corp (CGC) Stock Will Go? - InvestorsObserver

Tue, 21 Mar 2023
TLRY: Sell the Farm on These 4 Cannabis Stocks - StockNews.com

Tue, 21 Mar 2023
Acreage wins approval from British Columbia for Canopy Growth transaction and extends the exercise date by 60 days - MarketWatch

Mon, 20 Mar 2023
Unusual Put Option Trade in Canopy Growth (CGC) Worth $55.81K - Nasdaq

Mon, 20 Mar 2023
CGC stock, ACB and OGI stocks hit 52-week lows - Seeking Alpha

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 495 (M)
Shares Float 323 (M)
% Held by Insiders 34.7 (%)
% Held by Institutions 15.2 (%)
Shares Short 49,100 (K)
Shares Short P.Month 53,760 (K)

Stock Financials

EPS -5
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.88
Profit Margin (%) 0
Operating Margin (%) -115
Return on Assets (ttm) -6.8
Return on Equity (ttm) -112
Qtrly Rev. Growth -28.3
Gross Profit (p.s.) -0.17
Sales Per Share 0.89
EBITDA (p.s.) -0.84
Qtrly Earnings Growth 0
Operating Cash Flow -544 (M)
Levered Free Cash Flow -104 (M)

Stock Valuations

PE Ratio -0.38
PEG Ratio -0.2
Price to Book value 0.65
Price to Sales 2.13
Price to Cash Flow -1.73

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.